Intuitive Surgical, Inc. (NASDAQ:ISRG) EVP Sells $192,804.48 in Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) EVP Robert Desantis sold 396 shares of Intuitive Surgical stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $486.88, for a total value of $192,804.48. Following the sale, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at approximately $2,680,761.28. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Robert Desantis also recently made the following trade(s):

• On Monday, August 12th, Robert Desantis sold 240 shares of Intuitive Surgical stock. The shares were sold at an average price of $464.76, for a total transaction of $111,542.40.
• On Friday, July 26th, Robert Desantis sold 1,413 shares of Intuitive Surgical stock. The stock was sold at an average price of $438.60, for a total transaction of $619,741.80.
• On Monday, July 29th, Robert Desantis sold 376 shares of Intuitive Surgical stock. The shares were sold at an average price of $446.60, for a total transaction of $167,921.60.
• On Monday, June 10th, Robert Desantis sold 239 shares of Intuitive Surgical stock. The shares were sold at an average price of $416.60, for a total value of $99,567.40.
• On Tuesday, May 28th, Robert Desantis sold 584 shares of Intuitive Surgical stock. The stock was sold at an average price of $404.41, for a total value of $236,175.44.

Intuitive Surgical Trading Down 0.0 %

Shares of NASDAQ ISRG opened at $482.21 on Thursday. The company has a 50-day moving average of $451.45 and a 200 day moving average of $412.69. Intuitive Surgical, Inc. has a 12-month low of $254.85 and a 12-month high of $493.97. The stock has a market cap of $171.04 billion, a PE ratio of 87.04, a P/E/G ratio of 4.97 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Thursday, July 18th. The medical equipment provider reported $1.78 EPS for the quarter, beating the consensus estimate of $1.54 by $0.24. Intuitive Surgical had a return on equity of 13.04% and a net margin of 27.65%. The firm had revenue of $2.01 billion during the quarter, compared to analysts’ expectations of $1.97 billion. The business’s revenue for the quarter was up 14.5% on a year-over-year basis. During the same quarter last year, the firm earned $1.18 earnings per share. On average, sell-side analysts forecast that Intuitive Surgical, Inc. will post 5.22 EPS for the current fiscal year.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of ISRG. Kovack Advisors Inc. increased its holdings in shares of Intuitive Surgical by 29.2% during the 4th quarter. Kovack Advisors Inc. now owns 1,350 shares of the medical equipment provider’s stock worth $455,000 after buying an additional 305 shares during the last quarter. Golden State Equity Partners raised its position in Intuitive Surgical by 19.7% in the fourth quarter. Golden State Equity Partners now owns 1,454 shares of the medical equipment provider’s stock valued at $491,000 after purchasing an additional 239 shares during the period. Addison Advisors LLC lifted its stake in shares of Intuitive Surgical by 52.5% in the 4th quarter. Addison Advisors LLC now owns 311 shares of the medical equipment provider’s stock valued at $105,000 after purchasing an additional 107 shares during the last quarter. Legacy Capital Wealth Partners LLC purchased a new position in shares of Intuitive Surgical during the 4th quarter worth $275,000. Finally, Gilbert & Cook Inc. increased its position in shares of Intuitive Surgical by 6.5% during the 4th quarter. Gilbert & Cook Inc. now owns 3,437 shares of the medical equipment provider’s stock worth $1,160,000 after purchasing an additional 211 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts have issued reports on ISRG shares. Robert W. Baird boosted their price target on Intuitive Surgical from $487.00 to $503.00 and gave the company an “outperform” rating in a report on Friday, July 19th. BTIG Research boosted their target price on shares of Intuitive Surgical from $469.00 to $494.00 and gave the company a “buy” rating in a research note on Wednesday. Morgan Stanley raised their price target on shares of Intuitive Surgical from $375.00 to $460.00 and gave the company an “equal weight” rating in a research report on Monday, July 15th. Truist Financial upped their price objective on shares of Intuitive Surgical from $450.00 to $515.00 and gave the stock a “buy” rating in a research report on Tuesday, July 16th. Finally, The Goldman Sachs Group started coverage on Intuitive Surgical in a research report on Thursday, May 30th. They set a “buy” rating and a $500.00 target price on the stock. Six analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $446.45.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.